Showing 831-840 of 1655 results for "".
Baby Steps
https://modernaesthetics.com/ma-issues-index/2015-may-june/baby-steps/34530/Capitalize on Consumer Interest In Injectables
https://modernaesthetics.com/ma-issues-index/2015-jan-feb/virtual-voice/34561/Focusing on the Body: New Topical Products for Non-Facial Concerns
https://modernaesthetics.com/ma-issues-index/2014-july-aug/focusing-on-the-body-new-topical-products-for-non-facial-concerns/34610/Technology in Business: The Changing Face of Online Marketing
https://modernaesthetics.com/ma-issues-index/2014-may-june/technology-in-business-the-changing-face-of-online-marketing/34638/How To Select the Right Conference For You And Your Staff
https://modernaesthetics.com/ma-issues-index/2014-may-june/how-to-select-the-right-conference-for-you-and-your-staff/34641/Imaging Device Offers 3D Demonstration of Procedure Outcomes
https://modernaesthetics.com/ma-issues-index/2014-mar-apr/imaging-device-offers-3d-demonstration-of-procedure-outcomes/34648/- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb
- Aesthetics Biomedical, Skinceuticals Partner with Vivace Experience Featuring SkinCeuticals C E Ferulichttps://modernaesthetics.com/news/aesthetics-biomedica-skinceuticals-partner-with-vivace-experience-featuring-skinceuticals-c-e-ferulic/2473001/SkinCeuticals is teaming up with Aesthetics Biomedical’s Vivace Fractional Micro Needle Radio Frequency Treatment to create the professional Vivace Experience featuring SkinCeuticals C E Ferulic MaryAnn Guerra, CEO & President of Aesthetics Biomedical states, "Aesthetics
- Bonti's Novel Neurotoxin Shows Promise in Early Study of Scar Reduction After Mohs Surgeryhttps://modernaesthetics.com/news/bontis-novel-neurotoxin-shows-promise-in-early-study-of-scar-reduction-after-mohs-surgery/2472052/Topline results from Bonti’s SHINE-1 Phase 2a clinical trial suggest that its novel neurotoxin is safe and likely effective for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E (BoNT/E) with a unique clinical
- Allergan Reports Positive Phase 3 Data for New Short-acting Neurotoxinhttps://modernaesthetics.com/news/allergans-trenibotulinumtoxine-bonte-smoothes-glabellar-lines-quickly/2473513/Allergan Aesthetics’ trenibotulinumtoxinE (BoNT/E) performed well for the treatment of moderate to severe glabellar lines, according to topline results from two pivotal Phase 3 studies. BoNT/E is a novel botulinum neurotoxin serotype E with a quick onset of action